Comparing Two Treatments for IVIG-Resistant Kawasaki Disease – Evidence Update for Clinicians Children with resistant KD who received infliximab were more likely to have their fever resolve within 24 hours than were children who received a second dose of...
Read More
Comparing Two Treatments for Resistant Kawasaki Disease – Evidence Update for Parents Compared with children who received a second dose of IVIG, children who received infliximab were more likely to have their fever end within 24 hours. Children who...
Navigating Kawasaki Disease Together: A Dialogue with Experts for Patients and Caregivers The Kawasaki Disease Foundation teamed up with Kawasaki Disease Canada to host a symposium titled “Navigating Kawasaki Disease Together: A Dialogue with Experts for Patients...
Control Participants Needed: individuals with no history of KD and who are not first relatives of someone with a history of KD The Kawasaki Disease Research Center at the University of California, San Diego, is looking for participants for...